Streetbeat News

Stock Prices

EGRX

Scott Tarriff, the founder, President, and CEO of Eagle Pharmaceuticals, has resigned and retired effective immediately. Michael Graves, the Chairman of the company, will take over as Interim Executive Chairman.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 12:32 pm

VVOS

Vivos Therapeutics, Inc. has received FDA 510(k) clearance for its CARE oral appliances, designed to treat severe obstructive sleep apnea in adults. This includes the DNA, mRNA, and mmRNA oral appliances, marking a significant milestone for the company in the medical device and technology sector.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 12:32 pm

OKTA

Okta forecasts FY24 revenue to be between $2.243B and $2.245B, surpassing the estimated $2.21B. The company also projects adjusted EPS to be $1.47 - $1.48, which is higher than the estimated $1.18.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 12:28 pm

BOOM

KRP

RES

RNGR

WTI

The article lists the top 5 oversold energy stocks with potential for growth this quarter, based on their low Relative Strength Index (RSI) values. Ranger Energy Services (RNGR), DMC Global (BOOM), Kimbell Royalty Partners (KRP), RPC Inc. (RES), and W&T Offshore (WTI) are highlighted as having RSI values near or below 30, indicating they may be undervalued. The article provides recent performance details and stock price actions for each company.

Portfolio Pulse from Lisa Levin

November 29, 2023 | 12:26 pm

OKTA

Okta has reported its Q4 revenue forecast to be between $585M and $587M, surpassing the estimated $580.27M. The company also expects adjusted EPS to be between $0.50 and $0.51, which is higher than the estimated $0.35.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 12:26 pm

CRWD

CrowdStrike Holdings Inc (NASDAQ:CRWD) reported Q3 earnings that surpassed expectations with a 35% year-over-year revenue increase to $786 million, beating estimates of $777.13 million. Earnings per share were 82 cents, exceeding the forecast of 74 cents. The company expects Q4 earnings of 81-82 cents per share, above estimates of 78 cents, and full-year earnings of $2.95-$2.96 per share, compared to the expected $2.83. Following the earnings release, analysts raised their price targets on CRWD, with the stock rising 2.1% in pre-market trading.

Portfolio Pulse from Lisa Levin

November 29, 2023 | 12:24 pm

WDAY

Wells Fargo analyst Michael Turrin has maintained an Overweight rating on Workday (NASDAQ:WDAY) and increased the price target from $280 to $300.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 12:22 pm

BILI

Bilibili Inc (NASDAQ:BILI) reported flat year-on-year Q3 FY23 revenue of $795.7 million, missing consensus estimates of $817.3 million. The company's adjusted EPS loss widened to $(0.29), also missing the consensus loss of $(0.26). Despite a 14% increase in DAUs, mobile game revenues fell 33% Y/Y, while VAS revenues grew 17% Y/Y. Advertising revenue increased by 21% Y/Y, but revenue from IP derivatives and others dropped 23% Y/Y. Bilibili expects FY23 revenues at the lower end of their forecast due to disappointing mobile game revenues. The stock has declined 50.6% YTD and was down 4.12% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

November 29, 2023 | 12:22 pm

KEN

Kenon Holdings (NYSE:KEN) reported a 40.49% increase in Q3 sales to $229.00M, up from $163.00M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 12:21 pm

KMX

JP Morgan analyst Rajat Gupta has maintained an Underweight rating on CarMax (NYSE:KMX) and reduced the price target from $70 to $60.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 12:18 pm